Effect of BRCA1 Haplotype on Survival of Non–Small-Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy | Zendy

Hong-Tae Kim | Zendy; Jong Eun Lee | Zendy; EunSoon Shin | Zendy; Yeon-Kyeong Yoo | Zendy; Jae Hwa Cho | Zendy; Min-Hye Yun | Zendy; Yeul Hong Kim | Zendy; Se-Kyu Kim | Zendy; Hyun Jung Kim | Zendy; Tae Won Jang | Zendy; Seung-Min Kwak | Zendy; Chul-Soo Kim | Zendy; JeongSeon Ryu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of BRCA1 Haplotype on Survival of Non–Small-Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

Author(s) -

Hong-Tae Kim,

Jong Eun Lee,

EunSoon Shin,

Yeon-Kyeong Yoo,

Jae Hwa Cho,

Min-Hye Yun,

Yeul Hong Kim,

Se-Kyu Kim,

Hyun Jung Kim,

Tae Won Jang,

Seung-Min Kwak,

Chul-Soo Kim,

JeongSeon Ryu

Publication year - 2008

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2008.16.6496

Subject(s) - medicine , lung cancer , chemotherapy , adenocarcinoma , hazard ratio , gastroenterology , oncology , stage (stratigraphy) , haplotype , large cell , cancer , log rank test , small cell carcinoma , survival analysis , genotype , confidence interval , biology , gene , genetics , paleontology

To determine whether germ-line variations in BRCA1 affect outcome in non-small-cell lung cancer (NSCLC) patients treated with platinum combination chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research